ולוויר

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

VALACICLOVIR AS HYDROCHLORIDE 500 MG

Disponible depuis:

RAFA LABORATORIES LTD

Code ATC:

J05AB11

forme pharmaceutique:

FILM COATED TABLETS

Mode d'administration:

PER OS

Fabriqué par:

PHARMATHEN S.A., GREECE

Groupe thérapeutique:

VALACICLOVIR

indications thérapeutiques:

Valovir is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults. Valovir accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. The efficacy of valaciclovir in immunocompromised patients has not been established.Valovir is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. Valovir is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). Prophylaxis of cytomegalovirus infection and disease, following organ transplantation. For the treatment of cold sores (herpes labialis).

Date de l'autorisation:

2013-05-01